Anti-Infective Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Infective Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Anti-Infective Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Infective Treatment Market Perspective (2017-2028)
2.2 Anti-Infective Treatment Growth Trends by Region
2.2.1 Anti-Infective Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-Infective Treatment Historic Market Size by Region (2017-2022)
2.2.3 Anti-Infective Treatment Forecasted Market Size by Region (2023-2028)
2.3 Anti-Infective Treatment Market Dynamics
2.3.1 Anti-Infective Treatment Industry Trends
2.3.2 Anti-Infective Treatment Market Drivers
2.3.3 Anti-Infective Treatment Market Challenges
2.3.4 Anti-Infective Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Infective Treatment Players by Revenue
3.1.1 Global Top Anti-Infective Treatment Players by Revenue (2017-2022)
3.1.2 Global Anti-Infective Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Anti-Infective Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Infective Treatment Revenue
3.4 Global Anti-Infective Treatment Market Concentration Ratio
3.4.1 Global Anti-Infective Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Treatment Revenue in 2021
3.5 Anti-Infective Treatment Key Players Head office and Area Served
3.6 Key Players Anti-Infective Treatment Product Solution and Service
3.7 Date of Enter into Anti-Infective Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Infective Treatment Breakdown Data by Type
4.1 Global Anti-Infective Treatment Historic Market Size by Type (2017-2022)
4.2 Global Anti-Infective Treatment Forecasted Market Size by Type (2023-2028)
5 Anti-Infective Treatment Breakdown Data by Application
5.1 Global Anti-Infective Treatment Historic Market Size by Application (2017-2022)
5.2 Global Anti-Infective Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-Infective Treatment Market Size (2017-2028)
6.2 North America Anti-Infective Treatment Market Size by Type
6.2.1 North America Anti-Infective Treatment Market Size by Type (2017-2022)
6.2.2 North America Anti-Infective Treatment Market Size by Type (2023-2028)
6.2.3 North America Anti-Infective Treatment Market Share by Type (2017-2028)
6.3 North America Anti-Infective Treatment Market Size by Application
6.3.1 North America Anti-Infective Treatment Market Size by Application (2017-2022)
6.3.2 North America Anti-Infective Treatment Market Size by Application (2023-2028)
6.3.3 North America Anti-Infective Treatment Market Share by Application (2017-2028)
6.4 North America Anti-Infective Treatment Market Size by Country
6.4.1 North America Anti-Infective Treatment Market Size by Country (2017-2022)
6.4.2 North America Anti-Infective Treatment Market Size by Country (2023-2028)
6.4.3 the United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Infective Treatment Market Size (2017-2028)
7.2 Europe Anti-Infective Treatment Market Size by Type
7.2.1 Europe Anti-Infective Treatment Market Size by Type (2017-2022)
7.2.2 Europe Anti-Infective Treatment Market Size by Type (2023-2028)
7.2.3 Europe Anti-Infective Treatment Market Share by Type (2017-2028)
7.3 Europe Anti-Infective Treatment Market Size by Application
7.3.1 Europe Anti-Infective Treatment Market Size by Application (2017-2022)
7.3.2 Europe Anti-Infective Treatment Market Size by Application (2023-2028)
7.3.3 Europe Anti-Infective Treatment Market Share by Application (2017-2028)
7.4 Europe Anti-Infective Treatment Market Size by Country
7.4.1 Europe Anti-Infective Treatment Market Size by Country (2017-2022)
7.4.2 Europe Anti-Infective Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Treatment Market Size (2017-2028)
8.2 Asia-Pacific Anti-Infective Treatment Market Size by Type
8.2.1 Asia-Pacific Anti-Infective Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-Infective Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-Infective Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-Infective Treatment Market Size by Application
8.3.1 Asia-Pacific Anti-Infective Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-Infective Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-Infective Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-Infective Treatment Market Size by Region
8.4.1 Asia-Pacific Anti-Infective Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-Infective Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Infective Treatment Market Size (2017-2028)
9.2 Latin America Anti-Infective Treatment Market Size by Type
9.2.1 Latin America Anti-Infective Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Anti-Infective Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Anti-Infective Treatment Market Share by Type (2017-2028)
9.3 Latin America Anti-Infective Treatment Market Size by Application
9.3.1 Latin America Anti-Infective Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Anti-Infective Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Anti-Infective Treatment Market Share by Application (2017-2028)
9.4 Latin America Anti-Infective Treatment Market Size by Country
9.4.1 Latin America Anti-Infective Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Anti-Infective Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Treatment Market Size (2017-2028)
10.2 Middle East & Africa Anti-Infective Treatment Market Size by Type
10.2.1 Middle East & Africa Anti-Infective Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-Infective Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-Infective Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-Infective Treatment Market Size by Application
10.3.1 Middle East & Africa Anti-Infective Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-Infective Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-Infective Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-Infective Treatment Market Size by Country
10.4.1 Middle East & Africa Anti-Infective Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-Infective Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Anti-Infective Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Anti-Infective Treatment Introduction
11.2.4 Merck Revenue in Anti-Infective Treatment Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anti-Infective Treatment Introduction
11.3.4 Pfizer Revenue in Anti-Infective Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Anti-Infective Treatment Introduction
11.4.4 Novartis AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Anti-Infective Treatment Introduction
11.5.4 Gilead Sciences Revenue in Anti-Infective Treatment Business (2017-2022)
11.5.5 Gilead Sciences Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Anti-Infective Treatment Introduction
11.6.4 Abbott Revenue in Anti-Infective Treatment Business (2017-2022)
11.6.5 Abbott Recent Developments
11.7 Wyeth
11.7.1 Wyeth Company Details
11.7.2 Wyeth Business Overview
11.7.3 Wyeth Anti-Infective Treatment Introduction
11.7.4 Wyeth Revenue in Anti-Infective Treatment Business (2017-2022)
11.7.5 Wyeth Recent Developments
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Details
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Anti-Infective Treatment Introduction
11.8.4 Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2017-2022)
11.8.5 Sanofi-Aventis Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Anti-Infective Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 Johnson
11.10.1 Johnson Company Details
11.10.2 Johnson Business Overview
11.10.3 Johnson Anti-Infective Treatment Introduction
11.10.4 Johnson Revenue in Anti-Infective Treatment Business (2017-2022)
11.10.5 Johnson Recent Developments
11.11 Roche Pharma AG
11.11.1 Roche Pharma AG Company Details
11.11.2 Roche Pharma AG Business Overview
11.11.3 Roche Pharma AG Anti-Infective Treatment Introduction
11.11.4 Roche Pharma AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.11.5 Roche Pharma AG Recent Developments
11.12 Nanosphere
11.12.1 Nanosphere Company Details
11.12.2 Nanosphere Business Overview
11.12.3 Nanosphere Anti-Infective Treatment Introduction
11.12.4 Nanosphere Revenue in Anti-Infective Treatment Business (2017-2022)
11.12.5 Nanosphere Recent Developments
11.13 NanoViricides
11.13.1 NanoViricides Company Details
11.13.2 NanoViricides Business Overview
11.13.3 NanoViricides Anti-Infective Treatment Introduction
11.13.4 NanoViricides Revenue in Anti-Infective Treatment Business (2017-2022)
11.13.5 NanoViricides Recent Developments
11.14 Novabay Pharmaceuticals
11.14.1 Novabay Pharmaceuticals Company Details
11.14.2 Novabay Pharmaceuticals Business Overview
11.14.3 Novabay Pharmaceuticals Anti-Infective Treatment Introduction
11.14.4 Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022)
11.14.5 Novabay Pharmaceuticals Recent Developments
11.15 Obetech
11.15.1 Obetech Company Details
11.15.2 Obetech Business Overview
11.15.3 Obetech Anti-Infective Treatment Introduction
11.15.4 Obetech Revenue in Anti-Infective Treatment Business (2017-2022)
11.15.5 Obetech Recent Developments
11.16 Optimer Pharmaceuticals
11.16.1 Optimer Pharmaceuticals Company Details
11.16.2 Optimer Pharmaceuticals Business Overview
11.16.3 Optimer Pharmaceuticals Anti-Infective Treatment Introduction
11.16.4 Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022)
11.16.5 Optimer Pharmaceuticals Recent Developments
11.17 Basilea Pharmaceutica AG
11.17.1 Basilea Pharmaceutica AG Company Details
11.17.2 Basilea Pharmaceutica AG Business Overview
11.17.3 Basilea Pharmaceutica AG Anti-Infective Treatment Introduction
11.17.4 Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.17.5 Basilea Pharmaceutica AG Recent Developments
11.18 Daiichi Sankyo
11.18.1 Daiichi Sankyo Company Details
11.18.2 Daiichi Sankyo Business Overview
11.18.3 Daiichi Sankyo Anti-Infective Treatment Introduction
11.18.4 Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2017-2022)
11.18.5 Daiichi Sankyo Recent Developments
11.19 MerLion Pharma
11.19.1 MerLion Pharma Company Details
11.19.2 MerLion Pharma Business Overview
11.19.3 MerLion Pharma Anti-Infective Treatment Introduction
11.19.4 MerLion Pharma Revenue in Anti-Infective Treatment Business (2017-2022)
11.19.5 MerLion Pharma Recent Developments
11.20 Theravance
11.20.1 Theravance Company Details
11.20.2 Theravance Business Overview
11.20.3 Theravance Anti-Infective Treatment Introduction
11.20.4 Theravance Revenue in Anti-Infective Treatment Business (2017-2022)
11.20.5 Theravance Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-Infective Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Anti-Infective Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Anti-Infective Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-Infective Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anti-Infective Treatment Market Share by Region (2017-2022)
Table 8. Global Anti-Infective Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anti-Infective Treatment Market Share by Region (2023-2028)
Table 10. Anti-Infective Treatment Market Trends
Table 11. Anti-Infective Treatment Market Drivers
Table 12. Anti-Infective Treatment Market Challenges
Table 13. Anti-Infective Treatment Market Restraints
Table 14. Global Anti-Infective Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anti-Infective Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Anti-Infective Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Treatment as of 2021)
Table 17. Ranking of Global Top Anti-Infective Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anti-Infective Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-Infective Treatment Product Solution and Service
Table 21. Date of Enter into Anti-Infective Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anti-Infective Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Anti-Infective Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anti-Infective Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Anti-Infective Treatment Revenue Share by Application (2017-2022)
Table 29. Global Anti-Infective Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Anti-Infective Treatment Revenue Share by Application (2023-2028)
Table 31. North America Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Anti-Infective Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Anti-Infective Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Anti-Infective Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Anti-Infective Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Anti-Infective Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Anti-Infective Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Anti-Infective Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Anti-Infective Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Anti-Infective Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Anti-Infective Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Anti-Infective Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Anti-Infective Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Anti-Infective Treatment Product
Table 64. GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 65. GlaxoSmithKline Recent Developments
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Anti-Infective Treatment Product
Table 69. Merck Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 70. Merck Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Anti-Infective Treatment Product
Table 74. Pfizer Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Anti-Infective Treatment Product
Table 79. Novartis AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 80. Novartis AG Recent Developments
Table 81. Gilead Sciences Company Details
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Anti-Infective Treatment Product
Table 84. Gilead Sciences Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 85. Gilead Sciences Recent Developments
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Anti-Infective Treatment Product
Table 89. Abbott Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 90. Abbott Recent Developments
Table 91. Wyeth Company Details
Table 92. Wyeth Business Overview
Table 93. Wyeth Anti-Infective Treatment Product
Table 94. Wyeth Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 95. Wyeth Recent Developments
Table 96. Sanofi-Aventis Company Details
Table 97. Sanofi-Aventis Business Overview
Table 98. Sanofi-Aventis Anti-Infective Treatment Product
Table 99. Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 100. Sanofi-Aventis Recent Developments
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Anti-Infective Treatment Product
Table 104. Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Developments
Table 106. Johnson Company Details
Table 107. Johnson Business Overview
Table 108. Johnson Anti-Infective Treatment Product
Table 109. Johnson Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 110. Johnson Recent Developments
Table 111. Roche Pharma AG Company Details
Table 112. Roche Pharma AG Business Overview
Table 113. Roche Pharma AG Anti-Infective Treatment Product
Table 114. Roche Pharma AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 115. Roche Pharma AG Recent Developments
Table 116. Nanosphere Company Details
Table 117. Nanosphere Business Overview
Table 118. Nanosphere Anti-Infective Treatment Product
Table 119. Nanosphere Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 120. Nanosphere Recent Developments
Table 121. NanoViricides Company Details
Table 122. NanoViricides Business Overview
Table 123. NanoViricides Anti-Infective Treatment Product
Table 124. NanoViricides Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 125. NanoViricides Recent Developments
Table 126. Novabay Pharmaceuticals Company Details
Table 127. Novabay Pharmaceuticals Business Overview
Table 128. Novabay Pharmaceuticals Anti-Infective Treatment Product
Table 129. Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 130. Novabay Pharmaceuticals Recent Developments
Table 131. Obetech Company Details
Table 132. Obetech Business Overview
Table 133. Obetech Anti-Infective Treatment Product
Table 134. Obetech Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 135. Obetech Recent Developments
Table 136. Optimer Pharmaceuticals Company Details
Table 137. Optimer Pharmaceuticals Business Overview
Table 138. Optimer Pharmaceuticals Anti-Infective Treatment Product
Table 139. Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 140. Optimer Pharmaceuticals Recent Developments
Table 141. Basilea Pharmaceutica AG Company Details
Table 142. Basilea Pharmaceutica AG Business Overview
Table 143. Basilea Pharmaceutica AG Anti-Infective Treatment Product
Table 144. Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 145. Basilea Pharmaceutica AG Recent Developments
Table 146. Daiichi Sankyo Company Details
Table 147. Daiichi Sankyo Business Overview
Table 148. Daiichi Sankyo Anti-Infective Treatment Product
Table 149. Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 150. Daiichi Sankyo Recent Developments
Table 151. MerLion Pharma Company Details
Table 152. MerLion Pharma Business Overview
Table 153. MerLion Pharma Anti-Infective Treatment Product
Table 154. MerLion Pharma Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 155. MerLion Pharma Recent Developments
Table 156. Theravance Company Details
Table 157. Theravance Business Overview
Table 158. Theravance Anti-Infective Treatment Product
Table 159. Theravance Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 160. Theravance Recent Developments
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Infective Treatment Market Share by Type: 2021 VS 2028
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Anti-Infective Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Anti-Infective Treatment Report Years Considered
Figure 9. Global Anti-Infective Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Anti-Infective Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Anti-Infective Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Anti-Infective Treatment Market Share by Players in 2021
Figure 13. Global Top Anti-Infective Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Anti-Infective Treatment Revenue in 2021
Figure 15. North America Anti-Infective Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Anti-Infective Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Anti-Infective Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Anti-Infective Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Anti-Infective Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Anti-Infective Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Anti-Infective Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Anti-Infective Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Anti-Infective Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Anti-Infective Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Anti-Infective Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Anti-Infective Treatment Market Size Share by Region (2017-2028)
Figure 35. China Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Anti-Infective Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Anti-Infective Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Anti-Infective Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Anti-Infective Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Anti-Infective Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Anti-Infective Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Anti-Infective Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Anti-Infective Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 57. Novartis AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 58. Gilead Sciences Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 59. Abbott Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 60. Wyeth Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 61. Sanofi-Aventis Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 63. Johnson Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 64. Roche Pharma AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 65. Nanosphere Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 66. NanoViricides Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 67. Novabay Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 68. Obetech Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 69. Optimer Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 70. Basilea Pharmaceutica AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 71. Daiichi Sankyo Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 72. MerLion Pharma Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 73. Theravance Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Industry Market Size
